| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.30▼ | 1.29▲ | 1.29▲ | 1.31▼ | 1.33▼ |
| MA10 | 1.29▲ | 1.30▼ | 1.32▼ | 1.33▼ | 1.46▼ |
| MA20 | 1.29▲ | 1.32▼ | 1.31▼ | 1.33▼ | 1.35▼ |
| MA50 | 1.33▼ | 1.31▼ | 1.33▼ | 1.46▼ | 2.06▼ |
| MA100 | 1.31▼ | 1.33▼ | 1.33▼ | 1.43▼ | 2.05▼ |
| MA200 | 1.33▼ | 1.33▼ | 1.38▼ | 2.01▼ | 2.04▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.004▼ | -0.003▼ | 0.004▲ | 0.022▲ |
| RSI | 44.286▼ | 44.960▼ | 45.834▼ | 45.225▼ | 38.574▼ |
| STOCH | 50.000 | 5.556▼ | 13.172▼ | 41.687 | 34.135 |
| WILL %R | -50.000 | -95.833▼ | -71.875 | -68.182 | -74.311 |
| CCI | 80.135 | -52.965 | -47.863 | -42.445 | -61.281 |
|
Thursday, April 17, 2025 09:32 AM
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
|
|
Tuesday, April 15, 2025 07:00 AM
Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will attend the ...
|
|
Tuesday, April 15, 2025 01:00 AM
NORCROSS, Ga., April 15, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 1.40 | 1.40 | 1.28 | 1.30 | 77,739 |
| 30/04/25 | 1.24 | 1.42 | 1.2301 | 1.37 | 156,085 |
| 29/04/25 | 1.33 | 1.33 | 1.23 | 1.25 | 98,575 |
| 28/04/25 | 1.34 | 1.35 | 1.28 | 1.32 | 59,283 |
| 25/04/25 | 1.40 | 1.41 | 1.2822 | 1.32 | 157,029 |
| 24/04/25 | 1.35 | 1.42 | 1.33 | 1.42 | 133,990 |
| 23/04/25 | 1.34 | 1.378 | 1.315 | 1.34 | 66,141 |
| 22/04/25 | 1.35 | 1.37 | 1.2956 | 1.33 | 56,145 |
| 21/04/25 | 1.37 | 1.37 | 1.27 | 1.31 | 130,533 |
| 17/04/25 | 1.37 | 1.45 | 1.33 | 1.38 | 181,421 |
|
|
||||
|
|
||||
|
|